A Tumor-Associated Fibronectin Isoform Generated by Alternative Splicing of Messenger RNA Precursors
Fibronectin (FN) represents the mixture of a number of structurally different molecules (isoforms) whose make-up varies depending on the FN sources. FN from cultured transformed human cells has a very different isoform composition with respect to its normal counterpart. In fact, SV-40-transformed WI...
Saved in:
Published in | The Journal of cell biology Vol. 108; no. 3; pp. 1139 - 1148 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York, NY
Rockefeller University Press
01.03.1989
The Rockefeller University Press |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Fibronectin (FN) represents the mixture of a number of structurally different molecules (isoforms) whose make-up varies depending on the FN sources. FN from cultured transformed human cells has a very different isoform composition with respect to its normal counterpart. In fact, SV-40-transformed WI-38VAI3 human fibroblasts produce high levels of a FN isoform (B-FN) which is very poorly expressed in their normal, WI-38, counterpart. We have recently demonstrated that the B-FN isoform derives from a differential splicing pattern of the FN primary transcript which leads, in transformed cells, to a high level expression of the exon ED-B. Here we report on the production and characterization of a monoclonal antibody (BC-1) which recognizes an epitope within the protein sequence coded for by the ED-B exon. This monoclonal antibody makes it possible to carry out immunohistochemical analysis of the distribution of the ED-B-containing FN isoform (B-FN) in human tissues. The results show that while in normal, adult, human tissues total FN has a widespread distribution, the B-FN isoform is restricted only to synovial cells, to some vessels and areas of the interstitium of the ovary, and to the myometrium. On the contrary, the B-FN isoform has a much greater expression in fetal and tumor tissues. These results demonstrate that, in vivo, different FN isoforms have a differential distribution and indicate that the B-FN isoform may play a role in ontogenesis and oncogenetic processes. |
---|---|
AbstractList | Fibronectin (FN) represents the mixture of a number of structurally different molecules (isoforms) whose make-up varies depending on the FN sources. FN from cultured transformed human cells has a very different isoform composition with respect to its normal counterpart. In fact, SV-40-transformed WI-38VAI3 human fibroblasts produce high levels of a FN isoform (B-FN) which is very poorly expressed in their normal, WI-38, counterpart. We have recently demonstrated that the B-FN isoform derives from a differential splicing pattern of the FN primary transcript which leads, in transformed cells, to a high level expression of the exon ED-B. Here we report on the production and characterization of a monoclonal antibody (BC-1) which recognizes an epitope within the protein sequence coded for by the ED-B exon. This monoclonal antibody makes it possible to carry out immunohistochemical analysis of the distribution of the ED-B-containing FN isoform (B-FN) in human tissues. The results show that while in normal, adult, human tissues total FN has a widespread distribution, the B-FN isoform is restricted only to synovial cells, to some vessels and areas of the interstitium of the ovary, and to the myometrium. On the contrary, the B-FN isoform has a much greater expression in fetal and tumor tissues. These results demonstrate that, in vivo, different FN isoforms have a differential distribution and indicate that the B-FN isoform may play a role in ontogenesis and oncogenetic processes. Fibronectin (FN) represents the mixture of a number of structurally different molecules (isoforms) whose make-up varies depending on the FN sources. FN from cultured transformed human cells has a very different isoform composition with respect to its normal counterpart. In fact, SV-40-transformed WI-38VAI3 human fibroblasts produce high levels of a FN isoform (B-FN) which is very poorly expressed in their normal, WI-38, counterpart. We have recently demonstrated that the B-FN isoform derives from a differential splicing pattern of the FN primary transcript which leads, in transformed cells, to a high level expression of the exon ED-B (Zardi, L., B. Carnemolla, A. Siri, T. E. Petersen, G. Paolella, G. Sebastio, and F. E. Baralle. 1987. EMBO (Eur. Mol. Biol. Organ.) J. 6:2337-2342). Here we report on the production and characterization of a monoclonal antibody (BC-1) which recognizes an epitope within the protein sequence coded for by the ED-B exon. This monoclonal antibody makes it possible to carry out immunohistochemical analysis of the distribution of the ED-B-containing FN isoform (B-FN) in human tissues. The results show that while in normal, adult, human tissues total FN has a widespread distribution, the B-FN isoform is restricted only to synovial cells, to some vessels and areas of the interstitium of the ovary, and to the myometrium. On the contrary, the B-FN isoform has a much greater expression in fetal and tumor tissues. These results demonstrate that, in vivo, different FN isoforms have a differential distribution and indicate that the B-FN isoform may play a role in ontogenesis and oncogenetic processes. The authors have recently demonstrated that the B-FN isoform derives from a differential splicing pattern of the FN primary transcript which leads, in transformed cells, to a high level expression of the exon ED-B. Here the authors report on the production and characterization of a monoclonal antibody (BC-1) which recognizes an epitope within the protein sequence coded for by the ED-B exon. This monoclonal antibody makes it possible to carry out immunohistochemical analysis of the distribution of the ED-B-containing FN isoform (B-FN) in human tissues. The results show that while in normal, adult, human tissues total FN has a widespread distribution, the B-FN isoform is restricted only to synovial cells, to some vessels and areas of the interstitium of the ovary, and to the myometrium. |
Author | Zardi, Luciano Nicotra, Maria Rita Bigotti, Aldo Carnemolla, Barbara Siri, Annalisa Balza, Enrica Natali, Pier Giorgio |
Author_xml | – sequence: 1 givenname: Barbara surname: Carnemolla fullname: Carnemolla, Barbara – sequence: 2 givenname: Enrica surname: Balza fullname: Balza, Enrica – sequence: 3 givenname: Annalisa surname: Siri fullname: Siri, Annalisa – sequence: 4 givenname: Luciano surname: Zardi fullname: Zardi, Luciano – sequence: 5 givenname: Maria Rita surname: Nicotra fullname: Nicotra, Maria Rita – sequence: 6 givenname: Aldo surname: Bigotti fullname: Bigotti, Aldo – sequence: 7 givenname: Pier Giorgio surname: Natali fullname: Natali, Pier Giorgio |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=7196557$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/2646306$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkUtr3DAUhUVJSSdJt121oEXpzlPJetjeFExoHpA-yGMtJPl6qsGWJpIdyL-vJjNM21VXunA-nfs4J-jIBw8IvaNkSUnNPq-t2RZLtqSUNa_QggpOippycoQWhJS0aEQp3qCTlNaEEF5xdoyOS8klI3KBuhbfz2OIRZtSsE5P0OELZ2JuYifn8XUKfYgjvgQP8UU1z7gdJoheT-4J8N1mcNb5FQ49_gYpgV9BxLffW_wzgp1jCjGdode9HhK83b-n6OHi6_35VXHz4_L6vL0pLJdyKiSnpTE6z8sN7YngjWAcGCG0rxgXXQ-2lNCZUtRCiKojhvEepNYVsUaakp2iLzvfzWxG6Cz4KepBbaIbdXxWQTv1r-LdL7UKT6qkVLCGZoNPe4MYHmdIkxpdsjAM2kOYk6rqWvJ8xf-C2U7KkrEMLnegjSGlCP1hGkrUNkCVA9wWiqltgPnDh793OOD7xLL-ca_rZPXQR-2tSwesoo3Mt8nY-x22TlOIf5pKyjhh7DeE7q-t |
CODEN | JCLBA3 |
CitedBy_id | crossref_primary_10_1016_S0959_8049_05_80021_8 crossref_primary_10_1242_jcs_209619 crossref_primary_10_1002_ijc_2910640407 crossref_primary_10_1007_BF02630936 crossref_primary_10_1177_030089160108700629 crossref_primary_10_1016_0009_8981_93_90158_Z crossref_primary_10_1002_ijc_2910470603 crossref_primary_10_1016_j_yjmcc_2016_01_011 crossref_primary_10_1078_0171_9335_00283 crossref_primary_10_1177_00220345940730061001 crossref_primary_10_1016_j_exer_2017_08_017 crossref_primary_10_1089_105072503768499662 crossref_primary_10_1002_ijc_2910590507 crossref_primary_10_1016_S0006_291X_89_80034_8 crossref_primary_10_1158_1535_7163_MCT_13_0684 crossref_primary_10_1038_sj_bjc_6690809 crossref_primary_10_1002__SICI_1097_0142_19971215_80_12__2378__AID_CNCR7_3_0_CO_2_7 crossref_primary_10_1016_0014_5793_93_80479_E crossref_primary_10_1016_0012_1606_90_90114_X crossref_primary_10_1111_exd_12697 crossref_primary_10_1002_pmic_200300395 crossref_primary_10_1016_j_addr_2015_11_014 crossref_primary_10_1002__SICI_1098_2795_199603_43_3_392__AID_MRD14_3_0_CO_2_3 crossref_primary_10_1167_iovs_19_27171 crossref_primary_10_1038_sj_bjc_6603806 crossref_primary_10_1074_jbc_M111_303131 crossref_primary_10_1007_BF02899277 crossref_primary_10_1097_00000478_199811000_00010 crossref_primary_10_1074_jbc_M109_025924 crossref_primary_10_1002__SICI_1098_2264_199706_19_2_97__AID_GCC5_3_0_CO_2_V crossref_primary_10_1111_jdv_20163 crossref_primary_10_1006_excr_1997_3868 crossref_primary_10_1016_j_pep_2012_12_002 crossref_primary_10_1002_cmdc_200600181 crossref_primary_10_1371_journal_pone_0148103 crossref_primary_10_1007_s00259_009_1096_y crossref_primary_10_1002_ijc_10662 crossref_primary_10_1016_S0344_0338_11_80655_2 crossref_primary_10_1007_BF00666044 crossref_primary_10_1002_ijc_20952 crossref_primary_10_1038_s41573_023_00709_2 crossref_primary_10_1016_S0002_9440_10_64446_X crossref_primary_10_1016_S0021_9258_19_69545_1 crossref_primary_10_1111_j_1440_1711_2005_01318_x crossref_primary_10_1016_j_jprot_2010_05_017 crossref_primary_10_1177_002215540004800714 crossref_primary_10_1158_1541_7786_MCR_08_0195 crossref_primary_10_1016_j_lungcan_2008_07_013 crossref_primary_10_1007_s40336_021_00477_2 crossref_primary_10_1242_jcs_111_17_2655 crossref_primary_10_1016_S0964_1955_96_00074_7 crossref_primary_10_1002_ijc_2910610106 crossref_primary_10_1158_1078_0432_CCR_10_1420 crossref_primary_10_1016_0014_4827_92_90466_L crossref_primary_10_1016_j_jbiotec_2018_12_004 crossref_primary_10_1111_j_1699_0463_1994_tb05222_x crossref_primary_10_1054_bjom_2001_0702 crossref_primary_10_1016_j_ijom_2006_01_029 crossref_primary_10_1089_thy_2009_0332 crossref_primary_10_1002_adhm_201300597 crossref_primary_10_1158_1078_0432_CCR_06_0210 crossref_primary_10_1002__SICI_1097_0215_19980529_76_5_767__AID_IJC24_3_0_CO_2 crossref_primary_10_1016_S0945_053X_05_80026_5 crossref_primary_10_1038_nbt1197_1271 crossref_primary_10_1111_j_1432_1033_1992_tb16811_x crossref_primary_10_1016_S0959_8049_98_00041_0 crossref_primary_10_1126_scitranslmed_3006221 crossref_primary_10_1016_j_nbt_2019_04_002 crossref_primary_10_1016_S0021_9258_18_35923_4 crossref_primary_10_1016_S0046_8177_99_90095_3 crossref_primary_10_3109_15419069509081278 crossref_primary_10_1002_ijc_32603 crossref_primary_10_1186_1755_1536_4_21 crossref_primary_10_1016_0014_5793_90_80664_5 crossref_primary_10_1186_s12885_020_07055_1 crossref_primary_10_1002_aja_1001950102 crossref_primary_10_1002_ijc_2910470512 crossref_primary_10_1242_jcs_104_3_783 crossref_primary_10_1007_s10585_015_9754_x crossref_primary_10_18632_oncotarget_27772 crossref_primary_10_1517_14728222_9_3_491 crossref_primary_10_1074_jbc_270_15_8650 crossref_primary_10_1139_o96_091 crossref_primary_10_1038_s44321_024_00034_0 crossref_primary_10_1002__SICI_1097_0142_19971215_80_12__2484__AID_CNCR20_3_0_CO_2_7 crossref_primary_10_1161_01_ATV_17_5_1003 crossref_primary_10_1002_path_2833 crossref_primary_10_1186_s40364_023_00504_6 crossref_primary_10_1593_neo_101720 crossref_primary_10_1126_science_275_5299_547 crossref_primary_10_1016_j_addr_2017_05_011 crossref_primary_10_1016_S0003_9969_98_00035_1 crossref_primary_10_1016_j_leukres_2015_04_005 crossref_primary_10_1016_0363_5023_94_90057_4 crossref_primary_10_1007_BF02473239 crossref_primary_10_1002_1096_9896_2000_9999_9999___AID_PATH783_3_0_CO_2_P crossref_primary_10_1136_hrt_75_4_358 crossref_primary_10_1016_j_bbcan_2020_188354 crossref_primary_10_1128_mcb_14_5_3085_3093_1994 crossref_primary_10_1006_bbrc_2001_4264 crossref_primary_10_1186_1472_6750_11_104 crossref_primary_10_1097_00005537_200307000_00023 crossref_primary_10_1016_0014_5793_93_81494_K crossref_primary_10_1016_S0021_9258_19_47377_8 crossref_primary_10_1128_mcb_10_2_662_671_1990 crossref_primary_10_1002_0471143030_cb1005s60 crossref_primary_10_1038_nrc1627 crossref_primary_10_1083_jcb_139_1_295 crossref_primary_10_1186_1471_2407_6_8 crossref_primary_10_1177_002215549704500409 crossref_primary_10_1158_1535_7163_MCT_22_0099 crossref_primary_10_1002__SICI_1097_0215_19961104_68_3_397__AID_IJC20_3_0_CO_2_4 crossref_primary_10_1016_0014_4827_92_90100_M crossref_primary_10_1016_j_ydbio_2007_07_005 crossref_primary_10_1016_j_addr_2005_11_002 crossref_primary_10_1111_j_1432_1033_1992_tb16813_x crossref_primary_10_1002_pmic_200300689 crossref_primary_10_1002_ijc_2910460406 crossref_primary_10_1007_BF01464328 crossref_primary_10_1126_scitranslmed_abb2311 crossref_primary_10_1002_ijc_2910590104 crossref_primary_10_1016_S0021_9258_18_41717_6 crossref_primary_10_1038_nbt0302_264 crossref_primary_10_1111_j_1601_0825_1998_tb00282_x crossref_primary_10_1158_1078_0432_CCR_1004_0015 crossref_primary_10_1016_j_imbio_2009_06_005 crossref_primary_10_1002_path_2626 crossref_primary_10_1002_ijc_2910580405 crossref_primary_10_1093_humrep_der195 crossref_primary_10_1182_blood_2003_04_1039 crossref_primary_10_1007_BF00268932 crossref_primary_10_1111_j_1365_2249_1994_tb06560_x crossref_primary_10_1016_S0304_3835_98_00079_2 crossref_primary_10_1006_excr_2000_4869 crossref_primary_10_1016_j_ejca_2021_03_038 crossref_primary_10_1038_jid_2012_376 crossref_primary_10_1002_ijc_24473 crossref_primary_10_1158_1078_0432_CCR_05_0389 crossref_primary_10_1158_1078_0432_CCR_05_2448 crossref_primary_10_1046_j_1523_1755_1998_00009_x crossref_primary_10_1007_s00438_017_1372_7 crossref_primary_10_1007_BF02389692 crossref_primary_10_1242_jcs_109_12_2895 crossref_primary_10_1111_j_1749_6632_1990_tb17924_x crossref_primary_10_1080_00016480252814298 crossref_primary_10_1016_S0168_3659_97_00038_2 crossref_primary_10_1006_excr_1998_3946 crossref_primary_10_1016_0955_0674_89_90065_3 crossref_primary_10_1016_S0002_9394_02_01839_1 crossref_primary_10_1242_jcs_112_10_1449 crossref_primary_10_1111_j_1750_3639_2005_tb00117_x crossref_primary_10_1007_BF02365437 crossref_primary_10_1016_j_uct_2006_05_001 crossref_primary_10_1038_ki_1996_391 crossref_primary_10_1016_0922_3371_90_90056_3 crossref_primary_10_1016_j_preteyeres_2004_02_003 crossref_primary_10_1016_S0002_9440_10_64320_9 crossref_primary_10_1002_hed_21243 crossref_primary_10_1016_S0143_4004_97_80089_6 crossref_primary_10_1111_j_1699_0463_1992_tb04005_x crossref_primary_10_1002__SICI_1098_1136_199707_20_3_231__AID_GLIA7_3_0_CO_2_A crossref_primary_10_1242_jcs_103_2_423 crossref_primary_10_1016_S0049_3848_10_70033_5 crossref_primary_10_1007_s10456_013_9391_4 crossref_primary_10_1038_ki_1993_9 crossref_primary_10_1016_S0960_8966_96_00391_4 crossref_primary_10_1096_fj_10_163022 crossref_primary_10_1016_S0143_4004_97_80079_3 crossref_primary_10_1007_BF02890411 crossref_primary_10_1016_j_vaccine_2011_11_010 crossref_primary_10_1016_j_jbiotec_2014_06_017 crossref_primary_10_1097_00007890_200006270_00001 crossref_primary_10_1002_ddr_10161 crossref_primary_10_1038_s41467_017_01846_0 crossref_primary_10_1039_C6TB02008A crossref_primary_10_1371_journal_pone_0082878 crossref_primary_10_1111_j_1349_7006_1999_tb00750_x crossref_primary_10_1016_0378_1119_94_00778_Q crossref_primary_10_1517_14712598_2_4_371 crossref_primary_10_1006_bbrc_1999_0881 crossref_primary_10_1002_iub_493 crossref_primary_10_1242_dev_120_12_3657 crossref_primary_10_3109_15419069609010766 crossref_primary_10_1002_ijc_21677 crossref_primary_10_1016_S0940_9602_96_80102_6 crossref_primary_10_1016_j_jsb_2021_107696 crossref_primary_10_3109_15419069609010767 crossref_primary_10_1016_0003_2697_91_90551_4 crossref_primary_10_3390_cancers11091232 crossref_primary_10_1182_blood_V99_5_1659 crossref_primary_10_1016_S0021_9258_18_98735_1 crossref_primary_10_1074_jbc_274_9_5919 crossref_primary_10_18632_oncotarget_27726 crossref_primary_10_1016_S0046_8177_97_90284_7 crossref_primary_10_1038_nrclinonc_2009_52 crossref_primary_10_1016_j_oraloncology_2004_07_003 crossref_primary_10_1002__SICI_1097_0142_19980101_82_1_152__AID_CNCR19_3_0_CO_2_1 crossref_primary_10_1016_0092_8674_89_90294_8 crossref_primary_10_1016_S0002_9440_10_65388_6 crossref_primary_10_1016_j_addr_2014_07_011 crossref_primary_10_1002__SICI_1096_9896_199906_188_2_163__AID_PATH335_3_0_CO_2_1 crossref_primary_10_1182_blood_2008_06_160416 crossref_primary_10_1007_BF00941763 crossref_primary_10_1242_jcs_100_3_605 crossref_primary_10_1074_jbc_274_7_4400 crossref_primary_10_1074_jbc_M609211200 crossref_primary_10_1083_jcb_142_3_873 crossref_primary_10_1016_j_biopha_2017_07_160 crossref_primary_10_1002_ijc_2910540112 crossref_primary_10_1016_S0169_409X_97_00093_8 crossref_primary_10_1046_j_1365_2567_2000_00995_x crossref_primary_10_3109_01913129509014601 crossref_primary_10_1016_S0169_409X_01_00190_9 crossref_primary_10_1016_S0006_8993_97_00901_3 crossref_primary_10_1016_S0021_9258_18_35819_8 crossref_primary_10_1046_j_1439_0272_2002_00455_x crossref_primary_10_1093_rheumatology_38_11_1099 crossref_primary_10_1016_0012_1606_92_90291_N |
ContentType | Journal Article |
Copyright | Copyright 1989 The Rockefeller University Press 1989 INIST-CNRS |
Copyright_xml | – notice: Copyright 1989 The Rockefeller University Press – notice: 1989 INIST-CNRS |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7TM 8FD FR3 P64 RC3 7X8 5PM |
DOI | 10.1083/jcb.108.3.1139 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Nucleic Acids Abstracts Technology Research Database Engineering Research Database Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Genetics Abstracts Engineering Research Database Technology Research Database Nucleic Acids Abstracts Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE Genetics Abstracts MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1540-8140 |
EndPage | 1148 |
ExternalDocumentID | 10_1083_jcb_108_3_1139 2646306 7196557 1613403 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- -DZ -~X .55 .GJ 0VX 123 18M 1VV 29K 2WC 36B 3O- 4.4 53G 85S 9QQ AAUTI ABDNZ ABOCM ABPIV ABPPZ ABRJW ABZEH ACGFO ACGOD ACIWK ACKIV ACKOT ACNCT ACNKL ACPRK ACPVT ADBBV AENEX AEUPB AFFDN AFMIJ AFNDN AFOSN AFRAH AGHSJ AHJTV AI. ALMA_UNASSIGNED_HOLDINGS AOIJS B-7 BAWUL BTFSW C1A C45 CS3 D-I D0L DIK DU5 E3Z EBS EJD F20 F5P F9R FRP GX1 HF~ HGD HYE IH2 J5H JENOY JST JZ9 KQ8 MVM N9A O5R O5S OK1 P2P PQQKQ R.V RHF RHI RNS RPM RXW SJN TN5 TR2 TRP TWZ UHB UKR UPT VH1 VQA W8F WH7 WOQ X7L X7M XOL YNH YOC YQT YYP YZZ ZA5 ZCA ZGI ~KM 08R 34G 39C AAUGY ABPTK ABTAH ACYGS AGCDD AGJRR BKOMP EMB EMOBN H13 IQODW NHB OVD SV3 TAE TAF UBX YKV YSK YWH ZY4 AEILP CGR CUY CVF ECM EIF NPM AAYXX CITATION 7TM 8FD FR3 P64 RC3 7X8 5PM |
ID | FETCH-LOGICAL-c466t-6412bba9524b1f0549534e3001f7345dfec26edb2585557d0b34fe6aa70cb6b23 |
IEDL.DBID | RPM |
ISSN | 0021-9525 |
IngestDate | Tue Sep 17 20:49:26 EDT 2024 Fri Oct 25 09:37:58 EDT 2024 Fri Oct 25 22:07:33 EDT 2024 Thu Sep 26 18:52:38 EDT 2024 Sat Sep 28 08:36:44 EDT 2024 Sun Oct 29 17:06:44 EDT 2023 Fri Feb 02 07:01:33 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Characterization Human Immunohistochemistry Tissue Production Glycoproteins Monoclonal antibody Gene expression Localization Fibronectin Aminoacid sequence Isomer |
Language | English |
License | CC BY 4.0 This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c466t-6412bba9524b1f0549534e3001f7345dfec26edb2585557d0b34fe6aa70cb6b23 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2115391/ |
PMID | 2646306 |
PQID | 15366233 |
PQPubID | 23462 |
PageCount | 10 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_2115391 proquest_miscellaneous_78864000 proquest_miscellaneous_15366233 crossref_primary_10_1083_jcb_108_3_1139 pubmed_primary_2646306 pascalfrancis_primary_7196557 jstor_primary_1613403 |
PublicationCentury | 1900 |
PublicationDate | 1989-03-01 |
PublicationDateYYYYMMDD | 1989-03-01 |
PublicationDate_xml | – month: 03 year: 1989 text: 1989-03-01 day: 01 |
PublicationDecade | 1980 |
PublicationPlace | New York, NY |
PublicationPlace_xml | – name: New York, NY – name: United States |
PublicationTitle | The Journal of cell biology |
PublicationTitleAlternate | J Cell Biol |
PublicationYear | 1989 |
Publisher | Rockefeller University Press The Rockefeller University Press |
Publisher_xml | – name: Rockefeller University Press – name: The Rockefeller University Press |
SSID | ssj0004743 |
Score | 1.8205285 |
Snippet | Fibronectin (FN) represents the mixture of a number of structurally different molecules (isoforms) whose make-up varies depending on the FN sources. FN from... The authors have recently demonstrated that the B-FN isoform derives from a differential splicing pattern of the FN primary transcript which leads, in... |
SourceID | pubmedcentral proquest crossref pubmed pascalfrancis jstor |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 1139 |
SubjectTerms | Alternative splicing Analytical, structural and metabolic biochemistry Antibodies, Monoclonal Biological and medical sciences Biotechnology Cell Line Cell lines Cells Epitopes Exons Female Fetus Fetus - analysis Fibroblasts Fibronectins - analysis Fibronectins - genetics Fibronectins - immunology Fundamental and applied biological sciences. Psychology Glycoproteins Health. Pharmaceutical industry Humans Immunoenzyme Techniques Industrial applications and implications. Economical aspects Messenger RNA Miscellaneous Monoclonal antibodies Myometrium - analysis Neoplasms - analysis Ovary - analysis Production of active biomolecules Protein isoforms Proteins RNA Precursors - genetics RNA Splicing Synovial Membrane - analysis Tumor cell line Tumors |
Title | A Tumor-Associated Fibronectin Isoform Generated by Alternative Splicing of Messenger RNA Precursors |
URI | https://www.jstor.org/stable/1613403 https://www.ncbi.nlm.nih.gov/pubmed/2646306 https://search.proquest.com/docview/15366233 https://search.proquest.com/docview/78864000 https://pubmed.ncbi.nlm.nih.gov/PMC2115391 |
Volume | 108 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwEB21lSr1gii0ItAWH5A4ZTeJv5LjqqIqoFYIUam3yE5sWNRNVpvdQ_89M06ydBFcuCVyEkV-E_uN_fIG4B0XZCJWZbFVuoiFTDmOg3WFgNTkB4XDYUgUb27V9Z34dC_v90CO_8IE0X5l55PmYTFp5j-CtnK5qKajTmz65eYSkxbJi3S6D_sYoGOKPv4MqQepHGkPZCZHp8acT39Wlg4mnCqZFEdwiGxAcSp29GRO6mWJpJE0HXaT7-tb_I2A_qmjfDIxXT2HZwOjZLP-zY9hzzUv4LCvMfn4EuoZW28W7So2AxCuZh5z5Lahoa5h864l3sq-B_9parWPLOyhN8ETnHW0w40THGs9W5DTOK0Dsq-3M7Zc0WJ91666E7i7-vDt8joeSivElVBqHSuRZtYa7B9hU4-0rZBcOI5zltcIX-1dlSlX2wyzCSl1nVguvFPG6KSyymb8FA4afNFXwPB-kyhvee4S4aSyBs914X3O09SoLIL3Y-eWy95Boww73zkvERA6KHlJgERwEvr-92XINUTCIzjfwWLbrskOUeoI3o7YlPhx0I6HaVy76UoME4X8jv_7Cp3nCoexJILTHsvtw4fYiEDvgLxtJ1_u3RYM1-DPPYTn6_--8w0c9VI2krqdwcF6tXHnyH3W9gJZ_8fPFyHifwE0_QUh |
link.rule.ids | 230,315,730,783,787,888,27938,27939,53806,53808 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Pb5RAFH6pNY29-LNNqdbOwcQTLDC_4LhpbFbtboxpTW-EgZm66sJmYQ_1r_fNAGu30YPeIA8I8L2ZeY_38T2AN5RZEbEi9pWQqc94RHEeLAsEpLR6UDgdukRxOhOTK_bhml_vAB_-hXGk_ULNg-rHIqjmXx23crkoRgNPbPRpeoZJC6dpNHoAD3G8hmJI0offIWVPlrPsAx7zQasxoaNvhbIbAbW9TNJ92MN4QFDb7ujOqtQREy1LMm_wRZmuw8WfQtD7TMo7S9P5E_gyPFTHSPkerFsVFD_v6T3-81M_hcd9sErGnfkZ7OjqOex17StvX0A5Ju16Ua_8vMdYl8Rg-l1XdhatyLypbUhMbpy0tbWqW-LK85WTGyeNLZ7j2klqQxZWxNx-YiSfZ2OyXNk6QFOvmgO4On93eTbx-64NfsGEaH3BolipHF88U5HBiDDllGmKy6GR6Bml0UUsdKliTFQ4l2WoKDNa5LkMCyVUTA9ht8IbPQKC5-ehMIomOmSaC5XjvkyNSWgU5SL24O2AWrbsxDkyV1RPaIZI242MZhZpDw4cqL8PwzCGhdSDky2QN3ZplRa59OB0AD3DcWeLKXml63WTIRYCQ0f69yNkkgicIUMPDjsn2Vy8dzoP5Jb3bOxW8nvbgj7hpL97Hzj-7zNP4dHkcnqRXbyffXwJ-x1jzjLqXsFuu1rrEwyxWvXaDahfIW8mFg |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5BUVEvPFsRoNQHJE55-pUcV4VVeXRVISpVXKI4sWGBTVab7KH8esZOsuxWcOktkZ0ozje2ZzJfvgF4TZkVESsTXwmZ-YzHFNfBqkRAKqsHhcuhCxTPZ-Lskn244ldbpb4cab9U86D-tQjq-XfHrVwuynDkiYUX56cYtHCaxeGyMuFduIdzNkrHQH38JVIOhDnLQOAJH_UaUxr-KJU9CKitZ5IdwD76BILakkdbO1NPTrRMyaLFl2X6Khf_ckNvsim3tqfpQ_g6DqxnpfwM1p0Kyt83NB9vNfJH8GBwWsmk7_IY7uj6Cez3ZSyvn0I1Id160az8YsBaV8RgGN7UdjWtybxtrGtMvjmJa9uqrolL09dOdpy0NomOeyhpDFlYMXP7qZF8nk3IcmXzAW2zag_hcvruy-mZP1Rv8EsmROcLFidKFfjymYoNeoYZp0xT3BaNRAupjC4ToSuVYMDCuawiRZnRoihkVCqhEnoEezU-6DMgeH0RCaNoqiOmuVAFnsvMmJTGcSESD96MyOXLXqQjd8n1lOaItj3IaW7R9uDQAfu3G7ozLKIeHO8AvWmXVnGRSw9ORuBznH82qVLUulm3OeIh0IWk_-8h01TgShl5cNQbyubmg-F5IHcsaNNupb93W9AunAT4YAfPb33lCdy_eDvNP72ffXwBBz1xzhLrXsJet1rrY_S0OvXKzak_P6wolg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+tumor-associated+fibronectin+isoform+generated+by+alternative+splicing+of+messenger+RNA+precursors&rft.jtitle=The+Journal+of+cell+biology&rft.au=Carnemolla%2C+B&rft.au=Balza%2C+E&rft.au=Siri%2C+A&rft.au=Zardi%2C+L&rft.date=1989-03-01&rft.issn=0021-9525&rft.volume=108&rft.issue=3&rft.spage=1139&rft_id=info:doi/10.1083%2Fjcb.108.3.1139&rft_id=info%3Apmid%2F2646306&rft.externalDocID=2646306 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-9525&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-9525&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-9525&client=summon |